NINLIB 150MG CAPSULE

Form: Capsules

Pack Size: 30 CAPSULES

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹1171.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Ninlib 150MG Capsule, 30 capsules, salt nilotinib 150mg. NPPA has revised its MRP from Rs 4,161 to Rs 1,171 (72% lower) with effect from 09-11-2026; trade rate Rs 892.19. Group: BCR-ABL tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Abbott, MSN, Natco, Novartis, Reliance Life Sciences and others. Handling/counselling: must be taken on an empty stomach - no food 2 hours before and 1 hour after. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.